Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer
May 30, 2018
05:18
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. Linh Alejandro, a clinical oncology pharmacist at the University of California, San Diego Health Systems discusses the approval of olaparib for germline BRCA-mutated metastatic breast cancer.
ASCO Education